Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system.

Henry, Michel; Amor, Max; Cragg, A H; Porte, Jean-Marc; Henry, Isabelle; Amicabile, C; Tricoche, Olivier

doi:10.1148/radiology.201.3.8939221

Cited by 89 publications

(44 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nitinol is widely used for medical instrumentation because of its unique characteristics; [13][14][15][16][17][18][19][20][21][22] the rate of thrombogenicity and vascular injury is less than that with stainless steel. 23 Moreover, because of the self-expansion mechanism based on thermal memory, the expansion force of this stent is greater than that of other self-expandable stents.…”

Section: Discussionmentioning

confidence: 99%

Usefulness of the Symphony Nitinol Stent for Arteriosclerosis Obliterans.

Kinoshita

Suzuki

Hosokawa

et al. 2002

Circ J

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Usefulness of the Symphony Nitinol Stent for Arteriosclerosis Obliterans.

Kinoshita

Suzuki

Hosokawa

et al. 2002

Circ J

View full text Add to dashboard Cite

“…[2][3][4] Interestingly, these biological responses do not always occur after the implantation of grafts in conventional open surgery. To investigate these differences, we compared the biological responses to conventional open repair with those elicited during the endoluminal repair of AAAs.…”

Section: Is Endovascular Treatment Of Abdominal Aortic Aneurysms Lessmentioning

confidence: 99%

Is Endovascular Treatment of Abdominal Aortic Aneurysms Less Invasive Regarding the Biological Responses?

et al. 2000

View full text Add to dashboard Cite

To compare the biological responses following an endoluminal repair and a conventional open repair of abdominal aortic aneurysm (AAA), 14 patients who underwent an endoluminal repair (endograft group) and 26 who underwent an open repair (open group) were investigated. As markers of biological responses, interleukin-6 (IL-6) and -8 (IL-8), granulocyte elastase (GEL), white blood cell count (WBC), and serum C-reactive protein (CRP) were all measured preoperatively as well as on postoperative days (POD) 1, 3, and 6. In addition, the blood loss, duration of surgery, initial oral intake the day after surgery, and length of hospital stay were compared between both groups. The plasma levels of IL-6, GEL, CRP, and WBC were higher in the endograft group than in the open group, while the CRP, WBC, and GEL levels all peaked on POD 3. The plasma level of IL-6 remained high in the endograft group, compared with that in the open group throughout the study period. Conversely, blood loss, initial oral intake the day after surgery, and the length of hospital stay were all significantly greater in the open group than in the endograft group, although there was no significant difference in the duration of surgery between the two groups. These findings indicate that although the endoluminal repair of AAA is supposed to be less invasive, the biological responses tend to be greater because of the manipulation related to the insertion of the stent graft.

show abstract

“…Peripheral arterial disease (PAD) is one of the major manifestations of systemic atherosclerosis estimated to be present in 3% of people in the age range [40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59] years and in 20% of people over 70 years. 1,2 Approximately 5% of the patients with PAD will progress from intermittent claudication to critical limb ischaemia (CLI) in the due course of their disease.…”

Section: Introductionmentioning

confidence: 99%

“…Another potential indication for the application of this technology might be the treatment of femoro-popliteal aneurysms. 57 However, reports on the long-term results of the application of this technology are still pending. The impact of occluding all muscular perforating side branches is still uncertain.…”

mentioning

confidence: 99%

Current state of endovascular treatment of femoro-popliteal artery disease

Zeller

2007

Vasc Med

112

View full text Add to dashboard Cite

Considerable advances have been made over the last decade in percutaneous technology for the treatment of atherosclerotic diseases in the femoro-popliteal arteries. While treatment strategies are well defined in the iliac segment, where angioplasty and stenting perform well in appropriately selected lesions, the search for a durable transcatheter therapy for femoro-popliteal lesions continues. Whereas balloon angioplasty (PTA) is the accepted therapy for short lesions, long diffuse lesions are still recommended for surgical treatment. However, attractive new technologies ranging from transcatheter plaque excision to laser ablation, rotational atherectomy, cryoplasty, brachytherapy, and placement of drug-eluting stents to simple angioplasty with drug-coated balloons may have the potential to replace femoro-popliteal bypass surgery as a treatment of choice for complex lesions. This article reviews the status of percutaneous endovascular techniques for the treatment of femoro-popliteal artery occlusive disease.Key words: angioplasty; percutaneous intervention; peripheral occlusive disease; popliteal artery; stent; superficial femoral artery Albert-Ludwigs-University Freiburg, Freiburg, Germany and Department of Angiology, Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany Address for correspondence: Thomas Zeller, Abteilung Angiologie, Herz-Zentrum Bad Krozingen, Südring 15, D-79189 Bad Krozingen, Germany. Tel: ϩ49 7633/4020; Fax: ϩ49 7633/402-8208; E-mail: thomas.zeller@herzzentrum.de defined as target lesion revascularization (TLR). If another lesion at the target vessel site but not the index lesion itself needs to be treated during follow-up this intervention is defined as target vessel revascularization (TVR). Superficial femoral artery and popliteal artery diseaseThe superficial femoral artery (SFA) extending to the proximal popliteal artery segment is the most commonly diseased vasculature. More than 50% of all PAD cases involve the SFA and popliteal artery. Femoro-popliteal disease is often characterized by long, diffuse lesions, long occlusions (as opposed to mild focal stenoses). The unique slow-flow and highresistance environment in the femoro-popliteal region creates a milieu that seems to increase the prevalence of de novo disease. The same issues that lead to accumulation of plaque within the femoro-popliteal region likely amplify the response to injury and may explain the high incidence of restenosis following traditional angioplasty. 9 Femoro-popliteal occlusive disease is still the Achilles heel of the vascular specialist.The durability of femoro-popliteal intervention can be predicted by the pre-procedural angiographic characteristics of the target lesion. The TASC I and the updated TASC II document 6 divided the femoropopliteal lesions into four categories (Table 1). TASC A lesions are more suitable for endovascular procedures, whereas surgery is recommended for TASC D lesions. The TASC document clearly states that it takes more evidence to make firm recommendations about the role of an...

show abstract

Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system.

Abstract: Endoluminal bypass with a percutaneously delivered stent-graft is feasible. Technical results are good, and the number of complications is few at the iliac level. At the femoropopliteal level, patency is not as good and the number of complications is higher.

Cited by 89 publications

References 0 publications

Usefulness of the Symphony Nitinol Stent for Arteriosclerosis Obliterans.

Usefulness of the Symphony Nitinol Stent for Arteriosclerosis Obliterans.

Is Endovascular Treatment of Abdominal Aortic Aneurysms Less Invasive Regarding the Biological Responses?

Current state of endovascular treatment of femoro-popliteal artery disease

Contact Info

Product

Resources

About